1. Home
  2. BPTH vs UUU Comparison

BPTH vs UUU Comparison

Compare BPTH & UUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPTH
  • UUU
  • Stock Information
  • Founded
  • BPTH 2007
  • UUU 1969
  • Country
  • BPTH United States
  • UUU United States
  • Employees
  • BPTH N/A
  • UUU N/A
  • Industry
  • BPTH Biotechnology: Pharmaceutical Preparations
  • UUU Electronic Components
  • Sector
  • BPTH Health Care
  • UUU Technology
  • Exchange
  • BPTH Nasdaq
  • UUU Nasdaq
  • Market Cap
  • BPTH 2.2M
  • UUU 2.6M
  • IPO Year
  • BPTH N/A
  • UUU N/A
  • Fundamental
  • Price
  • BPTH $0.87
  • UUU $1.29
  • Analyst Decision
  • BPTH Strong Buy
  • UUU
  • Analyst Count
  • BPTH 2
  • UUU 0
  • Target Price
  • BPTH $30.00
  • UUU N/A
  • AVG Volume (30 Days)
  • BPTH 81.3K
  • UUU 48.6K
  • Earning Date
  • BPTH 11-13-2024
  • UUU 11-18-2024
  • Dividend Yield
  • BPTH N/A
  • UUU N/A
  • EPS Growth
  • BPTH N/A
  • UUU N/A
  • EPS
  • BPTH N/A
  • UUU N/A
  • Revenue
  • BPTH N/A
  • UUU $17,802,418.00
  • Revenue This Year
  • BPTH N/A
  • UUU N/A
  • Revenue Next Year
  • BPTH N/A
  • UUU N/A
  • P/E Ratio
  • BPTH N/A
  • UUU N/A
  • Revenue Growth
  • BPTH N/A
  • UUU N/A
  • 52 Week Low
  • BPTH $0.86
  • UUU $1.11
  • 52 Week High
  • BPTH $21.60
  • UUU $5.20
  • Technical
  • Relative Strength Index (RSI)
  • BPTH 34.38
  • UUU 57.36
  • Support Level
  • BPTH $0.86
  • UUU $1.11
  • Resistance Level
  • BPTH $0.92
  • UUU $1.20
  • Average True Range (ATR)
  • BPTH 0.06
  • UUU 0.08
  • MACD
  • BPTH 0.01
  • UUU 0.01
  • Stochastic Oscillator
  • BPTH 5.79
  • UUU 64.31

About BPTH Bio-Path Holdings Inc.

Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.

About UUU Universal Security Instruments Inc.

Universal Security Instruments Inc is a U.S based manufacturer and distributor of safety and security devices in the Peoples Republic of China . The company markets a line of residential smoke and carbon monoxide alarms under the trade names UNIVERSAL and USI Electric. It also markets products to the electrical distribution trade such as electrical and lighting distributors as well as manufactured housing companies. Its product portfolio consists of smoke and fire alarms, carbon monoxide alarms, multi-gas alarms, universal smoke sensing technology, and plug-in alarms.

Share on Social Networks: